• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病评估量表认知分量表与血管性痴呆评估量表在鉴别不同程度白质改变老年个体中的比较。LADIS研究。

Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.

作者信息

Ylikoski Raija, Jokinen Hanna, Andersen Pia, Salonen Oili, Madureira Sofia, Ferro Jose, Barkhof Frederik, van der Flier Wiesje, Schmidt Reinhold, Fazekas Franz, Scheltens Philip, Waldemar Gunhild, Salvadori Emilia, Pantoni Leonardo, Inzitari Domenico, Erkinjuntti Timo

机构信息

Memory Research Unit, Department of Neurology, University of Helsinki, Helsinki, Finland.

出版信息

Dement Geriatr Cogn Disord. 2007;24(2):73-81. doi: 10.1159/000103865. Epub 2007 Jun 12.

DOI:10.1159/000103865
PMID:17565216
Abstract

BACKGROUND/AIMS: The Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-cog) is a widely used rating instrument. The Vascular Dementia Assessment Scale cognitive subscale (VADAS-cog) includes additional tests reflecting mental speed and executive functions. The objective of this study was to compare the results of the two scales among subjects with various degrees of white matter hyperintensities (WMHs).

METHODS

In the multicentre, multinational Leukoaraiosis and Disability in the Elderly (LADIS) study, 616 non-disabled subjects between the ages of 65 and 84 were examined using MRI, the ADAS-cog and VADAS-cog. The WMH rating from the MRI divided the patients into groups of mild (n = 280), moderate (n = 187) and severe (n = 149) degrees of change.

RESULTS

Covariance analysis controlling for the effect of age and education revealed that the ADAS-cog differentiated only the mild and severe WMH groups, while the differences between all three groups were highly significant with the VADAS-cog.

CONCLUSIONS

The VADAS-cog significantly differentiated between all the white matter groups. In comparison, the ADAS-cog differentiated only severe changes. Accordingly, the VADAS-cog may be a more sensitive endpoint in studies of patients with white matter load and vascular burden of the brain.

摘要

背景/目的:阿尔茨海默病评估量表认知分量表(ADAS - cog)是一种广泛使用的评定工具。血管性痴呆评估量表认知分量表(VADAS - cog)包含反映心理速度和执行功能的附加测试。本研究的目的是比较不同程度脑白质高信号(WMH)患者中这两种量表的结果。

方法

在多中心、跨国的老年脑白质疏松症与残疾(LADIS)研究中,对616名年龄在65至84岁之间的非残疾受试者进行了磁共振成像(MRI)、ADAS - cog和VADAS - cog检查。MRI的WMH分级将患者分为轻度(n = 280)、中度(n = 187)和重度(n = 149)变化组。

结果

控制年龄和教育程度影响的协方差分析显示,ADAS - cog仅区分轻度和重度WMH组,而VADAS - cog在所有三组之间的差异均高度显著。

结论

VADAS - cog在所有脑白质组之间有显著差异。相比之下,ADAS - cog仅区分严重变化。因此,在脑白质负荷和血管负担患者的研究中,VADAS - cog可能是一个更敏感的终点指标。

相似文献

1
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.阿尔茨海默病评估量表认知分量表与血管性痴呆评估量表在鉴别不同程度白质改变老年个体中的比较。LADIS研究。
Dement Geriatr Cogn Disord. 2007;24(2):73-81. doi: 10.1159/000103865. Epub 2007 Jun 12.
2
Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.为老年人脑白质疏松症与残疾研究(LADIS)开发神经心理成套测验:经验与基线数据
Neuroepidemiology. 2006;27(2):101-16. doi: 10.1159/000095381.
3
The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.阿尔茨海默病评估量表认知分量表(ADAS-Cog)土耳其语版本在轻度和中度阿尔茨海默病患者及正常受试者中的有效性和可靠性。
Int J Geriatr Psychiatry. 2006 Mar;21(3):259-65. doi: 10.1002/gps.1457.
4
The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.阿尔茨海默病评估量表认知分量表中认知功能轻度受损或不确定患者的特征。
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):16-22. doi: 10.1097/01.wad.0000201846.22213.76.
5
The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.阿尔茨海默病评估工具使用达成共识的必要性:可行性研究(欧洲各地阿尔茨海默病中心的痴呆评估工具),欧洲阿尔茨海默病协会(EADC)的一项调查。
Int J Geriatr Psychiatry. 2005 Aug;20(8):744-8. doi: 10.1002/gps.1355.
6
How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?阿尔茨海默病评估量表认知部分(ADAS-cog)及其子量表在测量阿尔茨海默病认知功能障碍方面的效果如何?
Dement Geriatr Cogn Disord. 2009;28(1):63-9. doi: 10.1159/000230709. Epub 2009 Jul 30.
7
Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.阿尔茨海默病皮质下磁共振成像改变的认知后果:与小血管缺血性血管性痴呆的比较。
Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct;11(4):191-9.
8
The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.阿尔茨海默病评估量表 - 认知分量表:老年对照人群的常模数据
Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):236-40.
9
Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study.在为期三年的随访中,神经心理学预测因素与痴呆:来自 LADIS 研究的数据。
Dement Geriatr Cogn Disord. 2010;29(4):325-34. doi: 10.1159/000278333. Epub 2010 Apr 14.
10
Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).阿尔茨海默病评估量表的跨国比较与验证:痴呆症工具欧洲协调项目(EURO-HARPID)的结果
Int J Geriatr Psychiatry. 2004 Jan;19(1):41-50. doi: 10.1002/gps.1035.

引用本文的文献

1
Diagnosis of vascular cognitive impairment: recommendations of the scientific department of cognitive neurology and aging of the Brazilian Academy of Neurology.血管性认知障碍的诊断:巴西神经病学学会认知神经病学与衰老科学部的建议
Dement Neuropsychol. 2022 Nov 28;16(3 Suppl 1):53-72. doi: 10.1590/1980-5764-DN-2022-S104PT. eCollection 2022 Sep.
2
Serial neurocognitive changes following transcatheter aortic valve replacement: comparison between low and intermediate-high risk groups.经导管主动脉瓣置换术后的连续神经认知变化:低危和中高危风险组的比较。
Aging (Albany NY). 2022 Aug 5;14(15):6111-6127. doi: 10.18632/aging.204202.
3
Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.
丁苯酞治疗脑卒中后认知障碍的疗效与安全性:一项系统评价和Meta分析
Front Pharmacol. 2022 Jan 25;12:810297. doi: 10.3389/fphar.2021.810297. eCollection 2021.
4
Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative Design.脊髓小脑性共济失调 3 型的神经认知变化:系统评价与叙述性设计。
Cerebellum. 2022 Apr;21(2):314-327. doi: 10.1007/s12311-021-01282-3. Epub 2021 Jul 7.
5
Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatment.中风后认知障碍与痴呆:患病率、诊断及治疗
Degener Neurol Neuromuscul Dis. 2014 Feb 5;4:21-27. doi: 10.2147/DNND.S37353. eCollection 2014.
6
Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial.天智颗粒改善血管性痴呆的认知功能和行为和心理症状:一项随机对照试验。
J Transl Med. 2020 Feb 13;18(1):76. doi: 10.1186/s12967-020-02232-z.
7
Clinical practice guideline for cognitive impairment of cerebral small vessel disease.脑小血管病认知障碍临床实践指南
Aging Med (Milton). 2019 Jun 20;2(2):64-73. doi: 10.1002/agm2.12073. eCollection 2019 Jun.
8
Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial.天麻便纯制剂治疗轻至中度血管性痴呆的疗效与安全性:一项随机对照IIa期试验方案
Medicine (Baltimore). 2018 Dec;97(51):e13760. doi: 10.1097/MD.0000000000013760.
9
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.一项对纵向研究阿尔茨海默病生物标志物的系统评价。
J Alzheimers Dis. 2017;59(4):1359-1379. doi: 10.3233/JAD-170261.
10
Mesiotemporal atrophy and hippocampal diffusivity distinguish amnestic from non-amnestic vascular cognitive impairment.颞叶内侧萎缩和海马扩散率可区分遗忘型与非遗忘型血管性认知障碍。
Eur J Neurol. 2017 Jul;24(7):902-911. doi: 10.1111/ene.13299. Epub 2017 May 26.